Genetic research and testing in sport and exercise science: A review of the issues

Journal of Sports Sciences

Volumn 27, Issue 11, 2009, Pages 1109-1116

  Wackerhage, Henning ^a   Miah, Andy ^b   Harris, Roger C ^c   Montgomery, Hugh E ^d   Williams, Alun G ^e  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c UNIVERSITY OF CHICHESTER   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Ethics; Genetics; Performance testing; Sudden death

Indexed keywords

ANIMAL; ATHLETIC PERFORMANCE; ETHICS; EXERCISE; GENETIC SCREENING; GENETICS; HUMAN; MOUSE; REVIEW; SPORT; TRANSGENIC MOUSE;

ANIMALS; ATHLETIC PERFORMANCE; EXERCISE; GENETIC RESEARCH; GENETIC TESTING; HUMANS; MICE; MICE, TRANSGENIC; SPORTS;

EID: 74049141008     PISSN: 02640414     EISSN: 1466447X     Source Type: Journal    
DOI: 10.1080/02640410903114364     Document Type: Review

References (58)

1. Altmueller, J., Palmer, L. J., Fischer, G., Scherb, H., & Wjst, M. (2001). Genomewide scans of complex human diseases: True linkage is hard to find. American Journal of Human Genetics, 69, 936-950.
2. Blair, S. N., Kohl, H. W., III, Paffenbarger, R. S., Jr., Clark, D. G., Cooper, K. H., & Gibbons, L. W. (1989). Physical fitness and all-cause mortality: A prospective study of healthy men and women. Journal of the American Medical Association, 262, 2395-2401.
3. 2max response to exercise training: Results from the HERITAGE Family Study. Journal of Applied Physiology, 87, 1003-1008.
4. 2max in the sedentary state: The HERITAGE family study. Medicine and Science in Sports and Exercise, 30, 252-258.
5. Bray, M. S., Hagberg, J. M., Perusse, L., Rankinen, T., Roth, S. M., Wolfarth, B., et al. (2009). The human gene map for performance and health-related fitness phenotypes: The 2006- 2007 update. Medicine and Science in Sports and Exercise, 41, 35-73.
6. Brull, D., Dhamrait, S., Myerson, S., Erdmann, J., Woods, D., World, M., et al. (2001). Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet, 358, 1155-1156.
7. Bueno, O. F., De Windt, L. J., Tymitz, K. M., Witt, S. A., Kimball, T. R., Klevitsky, R., et al. (2000). The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO Journal, 19, 6341-6350.
8. Chanock, S. J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D. J., Thomas, G., et al. (2007). Replicating genotype-phenotype associations. Nature, 447, 655-660.
9. Coleman, M. E., DeMayo, F., Yin, K. C., Lee, H. M., Geske, R., Montgomery, C., et al. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. Journal of Biological Chemistry, 270, 12109-12116.
10. Corrado, D., Basso, C., Pavei, A., Michieli, P., Schiavon, M., & Thiene, G. (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. Journal of the American Medical Association, 296, 1593-1601.
11. Darbar, D. (2008). Genomics, heart failure and sudden cardiac death. Heart Failure Reviews (DOI: 10.1007/s10741-008- 9095-9).
12. Dhamrait, S. S., Payne, J. R., Li, P., Jones, A., Toor, I. S., Cooper, J. A., et al. (2003). Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension. European Heart Journal, 24, 1672-1680.
13. Dzau, V. J. (1988). Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation, 77, I4-I13.
14. Gayagay, G., Yu, B., Hambly, B., Boston, T., Hahn, A., Celermajer, D. S., et al. (1998). Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Human Genetics, 103, 48-50.
15. TM. Retrieved March 18, 2009, from http://www.gtg.com.au/HumanDNATesting/index.asp?menuid=070.110
16. Giudicelli, J. F., Richer, C., Richard, C., & Thuillez, C. (1991). Angiotensin converting enzyme inhibition: Systemic and regional hemodynamics in rats and humans. American Journal of Hypertension, 4, 258S-262S.
17. Gordon, S. E., Davis, B. S., Carlson, C. J., & Booth, F. W. (2001). ANG II is required for optimal overload-induced skeletal muscle hypertrophy. American Journal of Physiology: Endocrinology and Metabolism, 280, E150-E159.
18. Green, M. J., & Botkin, J. R. (2003). "Genetic exceptionalism" in medicine: Clarifying the differences between genetic and nongenetic tests. Annals of Internal Medicine, 138, 571-575.
19. 2max is associated with ACE genotype in postmenopausal women. Journal of Applied Physiology, 85, 1842-1846.
20. Hakimi, P., Yang, J., Casadesus, G., Massillon, D., Tolentino- Silva, F., Nye, C. K., et al. (2007). Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. Journal of Biological Chemistry, 282, 32844-32855.
21. Hudson, K. L., Holohan, M. K., & Collins, F. S. (2008). Keeping pace with the times - the Genetic Information Nondiscrimination Act of 2008. New England Journal of Medicine, 358, 2661-2663.
22. Lai, K. M., Gonzalez, M., Poueymirou, W. T., Kline, W. O., Na, E., Zlotchenko, E., et al. (2004). Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Molecular and Cellular Biology, 24, 9295-9304.
23. Lettre, G., Jackson, A. U., Gieger, C., Schumacher, F. R., Berndt, S. I., Sanna, S., et al. (2008). Identification of ten loci associated with height highlights new biological pathways in human growth. Nature Genetics, 40, 584-591.
24. Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., et al. (2002). Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature, 418, 797-801.
25. MacArthur, D. G., Seto, J. T., Chan, S., Quinlan, K. G., Raftery, J. M., Turner, N., et al. (2008). An Actn3 knockout mouse provides mechanistic insights into the association between α-actinin-3 deficiency and human athletic performance. Human Molecular Genetics, 17, 1076-1086.
26. Manchester, J., Skurat, A. V., Roach, P., Hauschka, S. D., & Lawrence, J. C., Jr. (1996). Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle. Proceedings of the National Academy of Sciences USA, 93, 10707-10711.
27. McPherron, A. C., Lawler, A. M., & Lee, S. J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 387, 83-90.
28. Montgomery, H. E., Marshall, R., Hemingway, H., Myerson, S., Clarkson, P., Dollery, C., et al. (1998). Human gene for physical performance. Nature, 393, 221-222.
29. Murgia, M., Serrano, A. L., Calabria, E., Pallafacchina, G., Lomo, T., & Schiaffino, S. (2000). Ras is involved in nerveactivity-dependent regulation of muscle genes. Nature Cell Biology, 2, 142-147.
30. Murray, T. H. (2008). Genetic exceptionalism and future diaries: Is genetic information different from other medical information? In M. A. Rothstein (Ed.), Genetic secrets: Protecting privacy and confidentiality in the genetic era (pp. 60-71). New Haven, CT: Yale University Press.
31. Myerson, S., Hemingway, H., Budget, R., Martin, J., Humphries, S., & Montgomery, H. (1999). Human angiotensin I-converting enzyme gene and endurance performance. Journal of Applied Physiology, 87, 1313-1316.
32. Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M., & Schiaffino, S. (2002). A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proceedings of the National Academy of Sciences USA, 99, 9213-9218.
33. Parsons, S. A., Millay, D. P., Wilkins, B. J., Bueno, O. F., Tsika, G. L., Neilson, J. R., et al. (2004). Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber-type switching but not hypertrophy. Journal of Biological Chemistry, 279, 26192-26200.
34. Parsons, S. A., Wilkins, B. J., Bueno, O. F., & Molkentin, J. D. (2003). Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice. Molecular and Cellular Biology, 23, 4331-4343.
35. Partners Healthcare (2008). Hypertrophic cardiomyopathy genetic test. Retrieved March 18, 2009, from http://www.hpcgg.org/LMM/comment/print/HCM_info.07.06.pdf
36. Rankinen, T., Perusse, L., Gagnon, J., Chagnon, Y. C., Leon, A. S., Skinner, J. S., et al. (2000a). Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. Journal of Applied Physiology, 88, 1029-1035.
37. Rankinen, T., Wolfarth, B., Simoneau, J. A., Maier-Lenz, D., Rauramaa, R., Rivera, M. A., et al. (2000b). No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. Journal of Applied Physiology, 88, 1571-1575.
38. Reneland, R., & Lithell, H. (1994). Angiotensin-converting enzyme in human skeletal muscle: A simple in vitro assay of activity in needle biopsy specimens. Scandinavian Journal of Clininical and Laboratory Investigation, 54, 105-111.
39. Rigat, B., Hubert, C., Henc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation, 86, 1343-1346.
40. Roth, S. M. (2008). Perspective on the future use of genomics in exercise prescription. Journal of Applied Physiology, 104, 1243-1245.
41. Santiago, C., Gonzalez-Freire, M., Serratosa, L., Morate, F. J., Meyer, T., Gomez-Gallego, F., et al. (2008). ACTN3 genotype in professional soccer players. British Journal of Sports Medicine, 42, 71-73.
42. Schuelke, M.,Wagner, K. R., Stolz, L. E., Hubner, C., Riebel, T., Komen, W., et al. (2004). Myostatin mutation associated with gross muscle hypertrophy in a child. New England Journal of Medicine, 350, 2682-2688.
43. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., & Rudnicki, M. A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell, 102, 777-786.
44. Silvestre, J. S., Bergaya, S., Tamarat, R., Duriez, M., Boulanger, C. M., & Levy, B. I. (2001). Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circulation Research, 89, 678-683.
45. Sonna, L. A., Sharp, M. A., Knapik, J. J., Cullivan, M., Angel, K. C., Patton, J. F., et al. (2001). Angiotensin-converting enzyme genotype and physical performance during US Army basic training. Journal of Applied Physiology, 91, 1355-1363.
46. The Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
47. Thomas, S., Reading, J., & Shephard, R. J. (1992). Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Canadian Journal of Sport Sciences, 17, 338-345.
48. Thomsen, I. (2008). Troubling history: Bulls' concern for Curry based on multiple incidents. Retrieved March 18, 2009, from http://sportsillustrated.cnn.com/2005/writers/ian_thomsen/10/13/curry/index.html
49. Tsianos, G., Sanders, J., Dhamrait, S., Humphries, S., Grant, S., & Montgomery, H. (2004). The ACE gene insertion/deletion polymorphism and elite endurance swimming. European Journal of Applied Physiology, 92, 360-362.
50. Wang, Y. X., Zhang, C. L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., et al. (2004). Regulation of muscle fiber type and running endurance by PPARdelta. Public Library of Science Biology, 2, e294.
51. Williams, A. G., Day, S. H., Folland, J. P., Gohlke, P., Dhamrait, S., & Montgomery, H. E. (2005). Circulating angiotensin converting enzyme activity is correlated with muscle strength. Medicine and Science in Sports and Exercise, 37, 944-948.
52. Williams, A. G., & Folland, J. P. (2008). Similarity of polygenic profiles limits the potential for elite human physical performance. Journal of Physiology, 586, 113-121.
53. Williams, A. G., Rayson, M. P., Jubb, M., World, M., Woods, D. R., Hayward, M., et al. (2000). The ACE gene and muscle performance. Nature, 403, 614.
54. Williams, A. G., Wackerhage, H., Miah, A., Harris, R. C., & Montgomery, H. (2007). Genetic Research and Testing in Sport and Exercise Science: British Association of Sport and Exercise Sciences Position Stand. Retrieved August 24, 2009, from http://www.bases.org.uk/write/documents/BASESpositionstand-aspublished.pdf
55. World Anti-Doping Association (2005). The Stockholm Declaration. Retrieved March 18, 2009, from http://www.wadaama.org/en/dynamic.ch2?pageCategory.id = 530
56. World Medical Association (2008). World Medical Association Declaration of Helsinki. Retrieved March 18, 2009, from http://www.wma.net/e/policy/pdf/17c.pdf
57. Yang, N., MacArthur, D. G., Gulbin, J. P., Hahn, A. G., Beggs, A. H., Easteal, S., et al. (2003). ACTN3 genotype is associated with human elite athletic performance. American Journal of Human Genetics, 73, 627-631.
58. Zhang, B., Tanaka, H., Shono, N., Miura, S., Kiyonaga, A., Shindo, M., et al. (2003). The I allele of the angiotensinconverting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clinical Genetics, 63, 139-144.